Suh-hang H. Juo
Taitung, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Assessing the Efficacy, Safety Profile, and Tolerability of Anti-microRNA-328 Anti-sense (SHJ002) for Dry Eye Disease: A Randomized Phase 2 Trial.
Journal: Clinical therapeutics
Published: November 06, 2025
Effects of Changes in Metabolic Syndrome Status on Cognitive Function: A 10-Year Study in a Middle-Aged Population.
Journal: The Kaohsiung journal of medical sciences
Published: July 19, 2025
Safety and Tolerability of Anti-microRNA-328 Ophthalmic Solution, SHJ002, in Pediatric Subjects: First-in-Human Clinical Study.
Journal: Clinical therapeutics
Published: May 31, 2024
Thrombospondin-1 associated with carotid intima-media thickness among individuals with hypertension.
Thrombospondin-1 associated with carotid intima-media thickness among individuals with hypertension.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: January 13, 2024
Cerebral Semaphorin3D is a novel risk factor for age-associated cognitive impairment.
Journal: Cell communication and signaling : CCS
Published: February 04, 2023
Inhibition of microRNA-328 Increases Ocular Mucin Expression and Conjunctival Goblet Cells.
Journal: Biomedicines
Published: December 20, 2022
miR-328-3p Affects Axial Length Via Multiple Routes and Anti-miR-328-3p Possesses a Potential to Control Myopia Progression.
Journal: Investigative ophthalmology & visual science
Published: November 09, 2022
MicroRNA Therapy for Dry Eye Disease.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: December 28, 2021
PDE4B Proposed as a High Myopia Susceptibility Gene in Chinese Population.
Journal: Frontiers in genetics
Published: September 14, 2021
Predictive Value of FOLFOX-Based Regimen, Long Interval, Hemoglobin Levels and Clinical Negative Nodal Status, and Postchemoradiotherapy CEA Levels for Pathological Complete Response in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy.
Journal: Journal of oncology
Published: July 05, 2019
Last Updated: 09/26/2026